mp:V3.0.0 testgegevens medicatiegegevensMGBMGR MVE addendum: verschil tussen versies
(Nieuwe pagina aangemaakt met ' __NUMBEREDHEADINGS__ {{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens MP9 3.0 - MVE: addendum inhoudelijke gegevens kwalificatie}} =Addenda voor inhoudelijke g...') |
|||
| (9 tussenliggende versies door 4 gebruikers niet weergegeven) | |||
| Regel 1: | Regel 1: | ||
__NUMBEREDHEADINGS__ | __NUMBEREDHEADINGS__ | ||
| − | {{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens MP9 3.0 - MVE: addendum inhoudelijke gegevens | + | {{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens MP9 3.0 - MVE: addendum inhoudelijke gegevens test}} |
=Addenda voor inhoudelijke gegevens= | =Addenda voor inhoudelijke gegevens= | ||
| Regel 7: | Regel 7: | ||
=== Scenarioset 0=== | === Scenarioset 0=== | ||
| − | <section begin=overview-MGB-0 /> | + | <section begin=overview-MGB-0 />Onderstaand scenario 0.1 bevat in het antwoord alle bouwstenen voor de patiënt. De daaropvolgende scenario's passen steeds een filter toe, waardoor het antwoord een subset van de bouwstenen uit scenario 0.1 bevat. Bij inhoudelijke gegevens staat om die reden alleen scenario 0.1 opgenomen. Deze omvat immers alle bouwstenen van alle subscenario's. |
| + | |||
| + | In de tabel staat bij elk scenario benoemd hoeveel van alle bouwstenen deze bevat (maar niet welke). | ||
{| class="wikitable" | {| class="wikitable" | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| Regel 25: | Regel 27: | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|0.7|| || <div>Verstrekkingen met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_QA1" invoeren) (Antwoord: bericht met 1 verstrekking)</div> | |0.7|| || <div>Verstrekkingen met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_QA1" invoeren) (Antwoord: bericht met 1 verstrekking)</div> | ||
| − | |||
| − | |||
|} | |} | ||
<section end=overview-MGB-0 /> | <section end=overview-MGB-0 /> | ||
| Regel 35: | Regel 35: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1.1|| || <div>Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie)</div>|| MBH_300_chronisch|| MBH_300_chronisch_MVE<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA | + | |1.1|| || <div>Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie)</div>|| MBH_300_chronisch-tmg|| MBH_300_chronisch_MVE-tmg<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmg |
|} | |} | ||
<section end=overview-MGB-1 /> | <section end=overview-MGB-1 /> | ||
| Regel 44: | Regel 44: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.1|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_300_toelichting|| MBH_300_toelichting_MVE | + | |2.1|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_300_toelichting-tmg|| MBH_300_toelichting_MVE-tmg |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.2|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen|| MBH_300_aanvullendeinformatiewensen_MVE | + | |2.2|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen-tmg|| MBH_300_aanvullendeinformatiewensen_MVE-tmg |
|} | |} | ||
<section end=overview-MGB-2 /> | <section end=overview-MGB-2 /> | ||
| Regel 55: | Regel 55: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_300_magistraalalleingredienten|| MBH_300_magistraalalleingredienten_MVE | + | |7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_300_magistraalalleingredienten-tmg|| MBH_300_magistraalalleingredienten_MVE-tmg |
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_300_magistraalactieveingredient-tmg|| MBH_300_magistraalactieveingredient_MVE-tmg | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7. | + | |7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr-tmg|| MBH_300_magistraal90miljoennr_MVE-tmg |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7. | + | |7.4|| Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt|| Vrije tekst product|| MBH_300_vrijetekstproduct-tmg|| MBH_300_vrijetekstproduct_MVE-tmg |
|} | |} | ||
<section end=overview-MGB-7 /> | <section end=overview-MGB-7 /> | ||
| + | === Scenarioset 8=== | ||
| + | <section begin=overview-MGB-8 /> | ||
| + | {| class="wikitable" | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.1|| || VV onder andermans MA|| MBH_300_VVandermansMA-tmg|| MBH_300_MVEandermansTA_MVE-tmg<br/>MBH_300_MVEandermansTA_andermansMVE-tmg | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.2|| || Staken andermans MA|| MBH_300_stakenandermansMA-tmg|| MBH_300_stakenandermansTA_andermansMVE-tmg | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.3|| || Onderbreken andermans MA (met kopie indicator)|| MBH_300_onderbrekenandermansMA-tmg|| MBH_300_onderbrekenandermansTA_andermansMVE-tmg | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.4|| || Wijzigen andermans MA|| MBH_300_wijzigenandermansMA-tmg|| MBH_300_wijzigenandermansTA_andermansMVE-tmg | ||
| + | |} | ||
| + | <section end=overview-MGB-8 /> | ||
=== Scenarioset 9=== | === Scenarioset 9=== | ||
<section begin=overview-MGB-9 /> | <section begin=overview-MGB-9 /> | ||
| Regel 68: | Regel 85: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |9.1b|| || GDS|| | + | |9.1a|| || Logistieke verbruiksperiode|| MBH_300_logistiekeverbruiksperiode_start_eind-tmg|| MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmg |
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |9.1b|| || GDS|| MBH_300_distributievorm_GDS-tmg|| MBH_300_distributievorm_GDS_MVE-tmg | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |9.1c|| || Verbruiksduur|| MBH_300_logistiekeverbruiksperiode_duur_dagen-tmg|| MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmg | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |9. | + | |9.2|| || Herhalende MVE onder een VV|| MBH_300_herhalingen-tmg|| MBH_300_herhalingen_MVE1-tmg<br/>MBH_300_herhalingen_MVE2-tmg<br/>MBH_300_herhalingen_MVE3-tmg |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |9.3|| Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden|| Afleverlocatie en aanschrijfdatum|| MBH_300_afleverlocatie|| MBH_300_afleverlocatie_MVE | + | |9.3|| Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden|| Afleverlocatie en aanschrijfdatum|| MBH_300_afleverlocatie-tmg|| MBH_300_afleverlocatie_MVE-tmg |
|} | |} | ||
<section end=overview-MGB-9 /> | <section end=overview-MGB-9 /> | ||
| Regel 81: | Regel 102: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |10.1|| || ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_MVE | + | |10.1|| || ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven-tmg|| MBH_300_ZINRvoorschrijven_MVE-tmg |
|} | |} | ||
<section end=overview-MGB-10 /> | <section end=overview-MGB-10 /> | ||
| + | === Scenarioset 14=== | ||
| + | <section begin=overview-MGB-14 /> | ||
| + | {| class="wikitable" | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MVE id | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |14.1|| || Een antwoord zonder medicatieverstrekkingen|| || | ||
| + | |} | ||
| + | <section end=overview-MGB-14 /> | ||
== Overzicht van scenario's voor ontvangend/raadplegend systeem == | == Overzicht van scenario's voor ontvangend/raadplegend systeem == | ||
=== Scenarioset 0=== | === Scenarioset 0=== | ||
| − | <section begin=overview-MGR-0 /> | + | <section begin=overview-MGR-0 />Onderstaand scenario 0.1 bevat in het antwoord alle bouwstenen voor de patiënt. De daaropvolgende scenario's passen steeds een filter toe, waardoor het antwoord een subset van de bouwstenen uit scenario 0.1 bevat. Bij inhoudelijke gegevens staat om die reden alleen scenario 0.1 opgenomen. Deze omvat immers alle bouwstenen van alle subscenario's. |
| + | |||
| + | In de tabel staat bij elk scenario benoemd hoeveel van alle bouwstenen deze bevat (maar niet welke). | ||
{| class="wikitable" | {| class="wikitable" | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| Regel 105: | Regel 137: | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
|0.7|| <div>Verstrekkingen met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_QA1" invoeren) (Antwoord: bericht met 1 verstrekking)</div> | |0.7|| <div>Verstrekkingen met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_QA1" invoeren) (Antwoord: bericht met 1 verstrekking)</div> | ||
| − | |||
| − | |||
|} | |} | ||
<section end=overview-MGR-0 /> | <section end=overview-MGR-0 /> | ||
| Regel 115: | Regel 145: | ||
| Scenario|| Beschrijving|| MBH id|| MVE id | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1.1|| <div>Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie)</div>|| MBH_300_chronisch|| MBH_300_chronisch_MVE<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA | + | |1.1|| <div>Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie)</div>|| MBH_300_chronisch-tmg|| MBH_300_chronisch_MVE-tmg<br/>MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmg |
|} | |} | ||
<section end=overview-MGR-1 /> | <section end=overview-MGR-1 /> | ||
| Regel 124: | Regel 154: | ||
| Scenario|| Beschrijving|| MBH id|| MVE id | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.1|| Toelichting|| MBH_300_toelichting|| MBH_300_toelichting_MVE | + | |2.1|| Toelichting|| MBH_300_toelichting-tmg|| MBH_300_toelichting_MVE-tmg |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.2|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen|| MBH_300_aanvullendeinformatiewensen_MVE | + | |2.2|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen-tmg|| MBH_300_aanvullendeinformatiewensen_MVE-tmg |
|} | |} | ||
<section end=overview-MGR-2 /> | <section end=overview-MGR-2 /> | ||
| Regel 135: | Regel 165: | ||
| Scenario|| Beschrijving|| MBH id|| MVE id | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.1|| Alle ingrediënten|| MBH_300_magistraalalleingredienten|| MBH_300_magistraalalleingredienten_MVE | + | |7.1|| Alle ingrediënten|| MBH_300_magistraalalleingredienten-tmg|| MBH_300_magistraalalleingredienten_MVE-tmg |
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |7.2|| Actief ingrediënt|| MBH_300_magistraalactieveingredient-tmg|| MBH_300_magistraalactieveingredient_MVE-tmg | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7. | + | |7.3|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr-tmg|| MBH_300_magistraal90miljoennr_MVE-tmg |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7. | + | |7.4|| Vrije tekst product|| MBH_300_vrijetekstproduct-tmg|| MBH_300_vrijetekstproduct_MVE-tmg |
|} | |} | ||
<section end=overview-MGR-7 /> | <section end=overview-MGR-7 /> | ||
| + | === Scenarioset 8=== | ||
| + | <section begin=overview-MGR-8 /> | ||
| + | {| class="wikitable" | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.1|| VV onder andermans MA|| MBH_300_VVandermansMA-tmg|| MBH_300_MVEandermansTA_MVE-tmg<br/>MBH_300_MVEandermansTA_andermansMVE-tmg | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.2|| Staken andermans MA|| MBH_300_stakenandermansMA-tmg|| MBH_300_stakenandermansTA_andermansMVE-tmg | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.3|| Onderbreken andermans MA (met kopie indicator)|| MBH_300_onderbrekenandermansMA-tmg|| MBH_300_onderbrekenandermansTA_andermansMVE-tmg | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |8.4|| Wijzigen andermans MA|| MBH_300_wijzigenandermansMA-tmg|| MBH_300_wijzigenandermansTA_andermansMVE-tmg | ||
| + | |} | ||
| + | <section end=overview-MGR-8 /> | ||
=== Scenarioset 9=== | === Scenarioset 9=== | ||
<section begin=overview-MGR-9 /> | <section begin=overview-MGR-9 /> | ||
| Regel 148: | Regel 195: | ||
| Scenario|| Beschrijving|| MBH id|| MVE id | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |9.1b|| GDS|| | + | |9.1a|| Logistieke verbruiksperiode|| MBH_300_logistiekeverbruiksperiode_start_eind-tmg|| MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmg |
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |9.1b|| GDS|| MBH_300_distributievorm_GDS-tmg|| MBH_300_distributievorm_GDS_MVE-tmg | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |9.1c|| Verbruiksduur|| MBH_300_logistiekeverbruiksperiode_duur_dagen-tmg|| MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmg | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |9. | + | |9.2|| Herhalende MVE onder een VV|| MBH_300_herhalingen-tmg|| MBH_300_herhalingen_MVE1-tmg<br/>MBH_300_herhalingen_MVE2-tmg<br/>MBH_300_herhalingen_MVE3-tmg |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |9.3|| Afleverlocatie en aanschrijfdatum|| MBH_300_afleverlocatie|| MBH_300_afleverlocatie_MVE | + | |9.3|| Afleverlocatie en aanschrijfdatum|| MBH_300_afleverlocatie-tmg|| MBH_300_afleverlocatie_MVE-tmg |
|} | |} | ||
<section end=overview-MGR-9 /> | <section end=overview-MGR-9 /> | ||
| Regel 161: | Regel 212: | ||
| Scenario|| Beschrijving|| MBH id|| MVE id | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |10.1|| ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_MVE | + | |10.1|| ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven-tmg|| MBH_300_ZINRvoorschrijven_MVE-tmg |
|} | |} | ||
<section end=overview-MGR-10 /> | <section end=overview-MGR-10 /> | ||
| + | === Scenarioset 14=== | ||
| + | <section begin=overview-MGR-14 /> | ||
| + | {| class="wikitable" | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | | Scenario|| Beschrijving|| MBH id|| MVE id | ||
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |14.1|| Een antwoord zonder medicatieverstrekkingen|| || | ||
| + | |} | ||
| + | <section end=overview-MGR-14 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | == TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | ||
<section begin=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /> | <section begin=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /> | ||
| Regel 181: | Regel 241: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 192: | Regel 252: | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
|style="background-color: white;"|XXX_Sonnenberg | |style="background-color: white;"|XXX_Sonnenberg | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| Regel 200: | Regel 263: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /> | ||
| − | ==== Scenario 0.1 - MBH_300_QA1==== | + | ==== Scenario 0.1 - MBH_300_QA1-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA1_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA1_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 212: | Regel 275: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA1_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 20 dagen om 09:00 uur | |style="background-color: white;"|T - 20 dagen om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 222: | Regel 285: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 236: | Regel 299: | ||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA1_VV | + | |style="background-color: white;"|MBH_300_QA1_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.1 - MBH_300_QA2==== | + | ==== Scenario 0.1 - MBH_300_QA2-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA2_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA2_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 252: | Regel 315: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA2_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 100 dagen om 09:04 uur | |style="background-color: white;"|T - 100 dagen om 09:04 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 262: | Regel 325: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|300 ml | |style="background-color: white;"|300 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 276: | Regel 339: | ||
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA2_VV | + | |style="background-color: white;"|MBH_300_QA2_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA2-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.1 - MBH_300_QA3==== | + | ==== Scenario 0.1 - MBH_300_QA3-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA3_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA3_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 292: | Regel 355: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA3_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA3_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 50 dagen om 09:10 uur | |style="background-color: white;"|T - 50 dagen om 09:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 302: | Regel 365: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|4000 ml | |style="background-color: white;"|4000 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 316: | Regel 379: | ||
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA3_VV | + | |style="background-color: white;"|MBH_300_QA3_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA3-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.1 - MBH_300_QA4==== | + | ==== Scenario 0.1 - MBH_300_QA4-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA4_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA4_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 332: | Regel 395: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA4_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 10 dagen om 09:12 uur | |style="background-color: white;"|T - 10 dagen om 09:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 342: | Regel 405: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 356: | Regel 419: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA4_VV | + | |style="background-color: white;"|MBH_300_QA4_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA4-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.1 - MBH_300_QA5==== | + | ==== Scenario 0.1 - MBH_300_QA5-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA5_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA5_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 372: | Regel 435: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA5_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA5_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 50 dagen om 09:15 uur | |style="background-color: white;"|T - 50 dagen om 09:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 382: | Regel 445: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|56 stuks | |style="background-color: white;"|56 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 396: | Regel 459: | ||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA5_VV | + | |style="background-color: white;"|MBH_300_QA5_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA5-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.1 - MBH_300_QA6==== | + | ==== Scenario 0.1 - MBH_300_QA6-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA6_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA6_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 412: | Regel 475: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA6_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA6_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 5 dagen om 09:18 uur | |style="background-color: white;"|T - 5 dagen om 09:18 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 422: | Regel 485: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 436: | Regel 499: | ||
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA6_VV | + | |style="background-color: white;"|MBH_300_QA6_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA6-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 450: | Regel 513: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-1 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | == TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | ||
| Regel 477: | Regel 543: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 488: | Regel 554: | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
|style="background-color: white;"|XXX_Sonnenberg | |style="background-color: white;"|XXX_Sonnenberg | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| Regel 496: | Regel 565: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-2 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-2 /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-2 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-2 /> | ||
| − | ==== Scenario 0.2 - MBH_300_QA1==== | + | ==== Scenario 0.2 - MBH_300_QA1-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA1_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA1_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 508: | Regel 577: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA1_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 20 dagen om 09:00 uur | |style="background-color: white;"|T - 20 dagen om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 518: | Regel 587: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 532: | Regel 601: | ||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA1_VV | + | |style="background-color: white;"|MBH_300_QA1_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 546: | Regel 615: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-2 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-2 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-2 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-2 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | == TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | ||
| Regel 573: | Regel 645: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 584: | Regel 656: | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
|style="background-color: white;"|XXX_Sonnenberg | |style="background-color: white;"|XXX_Sonnenberg | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| Regel 592: | Regel 667: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-3optioneel /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-3optioneel /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-3optioneel /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-3optioneel /> | ||
| − | ==== Scenario 0.3 - MBH_300_QA4==== | + | ==== Scenario 0.3 - MBH_300_QA4-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA4_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA4_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 604: | Regel 679: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA4_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 10 dagen om 09:12 uur | |style="background-color: white;"|T - 10 dagen om 09:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 614: | Regel 689: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 628: | Regel 703: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA4_VV | + | |style="background-color: white;"|MBH_300_QA4_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA4-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 642: | Regel 717: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-3optioneel /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-3optioneel /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-3optioneel /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-3optioneel /> | ||
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | == TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | ||
| Regel 669: | Regel 747: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 680: | Regel 758: | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
|style="background-color: white;"|XXX_Sonnenberg | |style="background-color: white;"|XXX_Sonnenberg | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| Regel 688: | Regel 769: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-4 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-4 /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-4 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-4 /> | ||
| − | ==== Scenario 0.4 - MBH_300_QA1==== | + | ==== Scenario 0.4 - MBH_300_QA1-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA1_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA1_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 700: | Regel 781: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA1_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 20 dagen om 09:00 uur | |style="background-color: white;"|T - 20 dagen om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 710: | Regel 791: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 724: | Regel 805: | ||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA1_VV | + | |style="background-color: white;"|MBH_300_QA1_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.4 - MBH_300_QA4==== | + | ==== Scenario 0.4 - MBH_300_QA4-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA4_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA4_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 740: | Regel 821: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA4_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 10 dagen om 09:12 uur | |style="background-color: white;"|T - 10 dagen om 09:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 750: | Regel 831: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 764: | Regel 845: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA4_VV | + | |style="background-color: white;"|MBH_300_QA4_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA4-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.4 - MBH_300_QA6==== | + | ==== Scenario 0.4 - MBH_300_QA6-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA6_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA6_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 780: | Regel 861: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA6_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA6_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 5 dagen om 09:18 uur | |style="background-color: white;"|T - 5 dagen om 09:18 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 790: | Regel 871: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 804: | Regel 885: | ||
|style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA6_VV | + | |style="background-color: white;"|MBH_300_QA6_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA6-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 818: | Regel 899: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-4 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-4 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-4 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-4 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | == TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | ||
| Regel 845: | Regel 929: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 856: | Regel 940: | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
|style="background-color: white;"|XXX_Sonnenberg | |style="background-color: white;"|XXX_Sonnenberg | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| Regel 864: | Regel 951: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-5 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-5 /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-5 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-5 /> | ||
| − | ==== Scenario 0.5 - MBH_300_QA2==== | + | ==== Scenario 0.5 - MBH_300_QA2-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA2_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA2_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 876: | Regel 963: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA2_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA2_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 100 dagen om 09:04 uur | |style="background-color: white;"|T - 100 dagen om 09:04 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 886: | Regel 973: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|300 ml | |style="background-color: white;"|300 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 900: | Regel 987: | ||
|style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA2_VV | + | |style="background-color: white;"|MBH_300_QA2_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA2-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.5 - MBH_300_QA3==== | + | ==== Scenario 0.5 - MBH_300_QA3-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA3_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA3_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 916: | Regel 1.003: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA3_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA3_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 50 dagen om 09:10 uur | |style="background-color: white;"|T - 50 dagen om 09:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 926: | Regel 1.013: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|4000 ml | |style="background-color: white;"|4000 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 940: | Regel 1.027: | ||
|style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA3_VV | + | |style="background-color: white;"|MBH_300_QA3_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA3-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.5 - MBH_300_QA5==== | + | ==== Scenario 0.5 - MBH_300_QA5-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA5_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA5_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 956: | Regel 1.043: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA5_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA5_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 50 dagen om 09:15 uur | |style="background-color: white;"|T - 50 dagen om 09:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 966: | Regel 1.053: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|56 stuks | |style="background-color: white;"|56 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 980: | Regel 1.067: | ||
|style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA5_VV | + | |style="background-color: white;"|MBH_300_QA5_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA5-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 994: | Regel 1.081: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-5 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-5 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-5 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-5 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | == TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | ||
| Regel 1.021: | Regel 1.111: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 1.032: | Regel 1.122: | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
|style="background-color: white;"|XXX_Sonnenberg | |style="background-color: white;"|XXX_Sonnenberg | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| Regel 1.040: | Regel 1.133: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-6 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-6 /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-6 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-6 /> | ||
| − | ==== Scenario 0.6 - MBH_300_QA1==== | + | ==== Scenario 0.6 - MBH_300_QA1-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA1_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA1_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.052: | Regel 1.145: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA1_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 20 dagen om 09:00 uur | |style="background-color: white;"|T - 20 dagen om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.062: | Regel 1.155: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.076: | Regel 1.169: | ||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA1_VV | + | |style="background-color: white;"|MBH_300_QA1_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 0.6 - MBH_300_QA4==== | + | ==== Scenario 0.6 - MBH_300_QA4-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA4_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA4_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.092: | Regel 1.185: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA4_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 10 dagen om 09:12 uur | |style="background-color: white;"|T - 10 dagen om 09:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.102: | Regel 1.195: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.116: | Regel 1.209: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA4_VV | + | |style="background-color: white;"|MBH_300_QA4_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA4-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.130: | Regel 1.223: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-6 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-6 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-6 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-6 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | == TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)== | ||
| Regel 1.157: | Regel 1.253: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 1.168: | Regel 1.264: | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
|style="background-color: white;"|XXX_Sonnenberg | |style="background-color: white;"|XXX_Sonnenberg | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Adresgegevens | ||
| + | |style="background-color: white;"|krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| Regel 1.176: | Regel 1.275: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-7 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-7 /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-7 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-7 /> | ||
| − | ==== Scenario 0.7 - MBH_300_QA1==== | + | ==== Scenario 0.7 - MBH_300_QA1-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA1_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_QA1_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.188: | Regel 1.287: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_QA1_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 20 dagen om 09:00 uur | |style="background-color: white;"|T - 20 dagen om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.198: | Regel 1.297: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|60 stuks | |style="background-color: white;"|60 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.212: | Regel 1.311: | ||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_QA1_VV | + | |style="background-color: white;"|MBH_300_QA1_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_QA1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.226: | Regel 1.325: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-7 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-7 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset0-v30-0-7 /><section end=mg-mp-mg-tst-MVE-Scenarioset0-v30-0-7 /> | ||
| − | == TEST Medicatiegegevens MVE Scenarioset | + | == TEST Medicatiegegevens MVE Scenarioset 1== |
| − | <section begin=mg-mp-mg-tst-MVE- | + | <section begin=mg-mp-mg-tst-MVE-Scenarioset1-v30-1-1 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset1-v30-1-1 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 1.247: | Regel 1.349: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|D. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan | + | |rowspan="2"| |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Dijks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900468 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|21 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mg-mp-mg-tst-MVE- | + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset1-v30-1-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset1-v30-1-1 /> |
| − | == | + | ==== Scenario 1.1 - MBH_300_chronisch-tmg==== |
| − | + | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Identificatie |
| + | |style="background-color: white;"|MBH_300_chronisch_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 30 dagen om 12:32 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="3"|VerstrekteHoeveelheid | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="3"| | ||
|style="background-color: white;"|21 stuks | |style="background-color: white;"|21 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.343: | Regel 1.407: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_chronisch_VV | + | |style="background-color: white;"|MBH_300_chronisch_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_chronisch-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.357: | Regel 1.421: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_chronisch_MVE_extraMVEbestaandeTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 10 dagen om 12:35 uur | |style="background-color: white;"|T - 10 dagen om 12:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.367: | Regel 1.431: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|90 stuks | |style="background-color: white;"|90 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.381: | Regel 1.445: | ||
|style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA | + | |style="background-color: white;"|MBH_300_chronisch_VV_extraVVbestaandeMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_chronisch-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.395: | Regel 1.459: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset1-v30-1-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset1-v30-1-1 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset1-v30-1-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset1-v30-1-1 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 2== | == TEST Medicatiegegevens MVE Scenarioset 2== | ||
| Regel 1.422: | Regel 1.489: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 1.438: | Regel 1.505: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-1 /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-1 /> | ||
| − | ==== Scenario 2.1 - MBH_300_toelichting==== | + | ==== Scenario 2.1 - MBH_300_toelichting-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_toelichting_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_toelichting_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.450: | Regel 1.517: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toelichting_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_toelichting_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 21 dagen om 09:02 uur | |style="background-color: white;"|T - 21 dagen om 09:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.460: | Regel 1.527: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
|style="background-color: white;"|30 stuks | |style="background-color: white;"|30 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.477: | Regel 1.544: | ||
|style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | |style="background-color: white;"|Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_toelichting_VV | + | |style="background-color: white;"|MBH_300_toelichting_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_toelichting-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.491: | Regel 1.558: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset2-v30-2-1 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset2-v30-2-1 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 2== | == TEST Medicatiegegevens MVE Scenarioset 2== | ||
| Regel 1.518: | Regel 1.588: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 1.534: | Regel 1.604: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-2 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-2 /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-2 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-2 /> | ||
| − | ==== Scenario 2.2 - MBH_300_aanvullendeinformatiewensen==== | + | ==== Scenario 2.2 - MBH_300_aanvullendeinformatiewensen-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_aanvullendeinformatiewensen_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_aanvullendeinformatiewensen_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.546: | Regel 1.616: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T - 5 dagen om 09:06 uur | |style="background-color: white;"|T - 5 dagen om 09:06 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.556: | Regel 1.626: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|40 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 1.568: | Regel 1.638: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|FENETICILLINE 500MG | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieverstrekkingAanvullendeInformatie | ||
| + | |style="background-color: white;"|Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_VV | + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.584: | Regel 1.657: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-2 /><section end=mg-mp-mg-tst-MVE-Scenarioset2-v30-2-2 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset2-v30-2-2 /><section end=mg-mp-mg-tst-MVE-Scenarioset2-v30-2-2 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | ||
| Regel 1.611: | Regel 1.687: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 1.630: | Regel 1.706: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-1 /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-1 /> | ||
| − | ==== Scenario 7.1 - MBH_300_magistraalalleingredienten==== | + | ==== Scenario 7.1 - MBH_300_magistraalalleingredienten-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalalleingredienten_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalalleingredienten_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.642: | Regel 1.718: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T om 13:00 uur | |style="background-color: white;"|T om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.652: | Regel 1.728: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|VerstrekteHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|50 ml |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="11"| | |rowspan="11"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.671: | Regel 1.747: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Sterkte | |colspan="2"|Sterkte | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|10 gram per 100 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Ingredient | |colspan="4"|Ingredient | ||
| Regel 1.681: | Regel 1.757: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Sterkte | |colspan="2"|Sterkte | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|90 gram per 100 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_magistraalalleingredienten_VV | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.701: | Regel 1.777: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset7-v30-7-1 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset7-v30-7-1 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | ||
| Regel 1.728: | Regel 1.807: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 1.747: | Regel 1.826: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-2 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-2 /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-2 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-2 /> | ||
| − | ==== Scenario 7.2 - MBH_300_magistraalactieveingredient==== | + | ==== Scenario 7.2 - MBH_300_magistraalactieveingredient-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalactieveingredient_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraalactieveingredient_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.759: | Regel 1.838: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T om 13:05 uur | |style="background-color: white;"|T om 13:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.769: | Regel 1.848: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|VerstrekteHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|75 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.788: | Regel 1.867: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Sterkte | |colspan="2"|Sterkte | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|80 gram per 100 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_magistraalactieveingredient_VV | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.808: | Regel 1.887: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-2 /><section end=mg-mp-mg-tst-MVE-Scenarioset7-v30-7-2 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-2 /><section end=mg-mp-mg-tst-MVE-Scenarioset7-v30-7-2 /> | ||
== TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== | ||
| Regel 1.835: | Regel 1.917: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 1.854: | Regel 1.936: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-3 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-3 /> | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-3 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-3 /> | ||
| − | ==== Scenario 7.3 - MBH_300_magistraal90miljoennr==== | + | ==== Scenario 7.3 - MBH_300_magistraal90miljoennr-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraal90miljoennr_MVE | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieverstrekking MBH_300_magistraal90miljoennr_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.866: | Regel 1.948: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MVE (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MedicatieverstrekkingsDatumTijd |
|style="background-color: white;"|T om 13:08 uur | |style="background-color: white;"|T om 13:08 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.876: | Regel 1.958: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|VerstrekteHoeveelheid |
|style="background-color: white;"|100 gram | |style="background-color: white;"|100 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="8"| | |rowspan="8"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductCode |
| − | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11. | + | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.898: | Regel 1.980: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Sterkte | |colspan="2"|Sterkte | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|10 gram per 100 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"|MBH_300_magistraal90miljoennr_VV | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.918: | Regel 2.000: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-3 /><section end=mg-mp-mg-tst-MVE-Scenarioset7-v30-7-3 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-3 /><section end=mg-mp-mg-tst-MVE-Scenarioset7-v30-7-3 /> | ||
| − | == TEST Medicatiegegevens MVE Scenarioset | + | == TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)== |
| − | <section begin=mg-mp-mg-tst-MVE- | + | <section begin=mg-mp-mg-tst-MVE-Scenarioset7-v30-7-4 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-4 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 1.945: | Regel 2.030: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 1.955: | Regel 2.040: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Rambaran Mishre |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900948 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|8 nov 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mg-mp-mg-tst-MVE- | + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-4 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-4 /> |
| − | ==== Scenario | + | ==== Scenario 7.4 - MBH_300_vrijetekstproduct-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_vrijetekstproduct_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.976: | Regel 2.061: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_vrijetekstproduct_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 15:50 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 1.986: | Regel 2.071: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|4 stuks |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="3"| |
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|ProductNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Jemperli 500 mg/ 10 mL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_vrijetekstproduct_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_vrijetekstproduct-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.017: | Regel 2.100: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| − | |}<section end=mbhs-mg-mp-mg-tst-MVE- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | == TEST Medicatiegegevens MVE Scenarioset | + | |colspan="2"|Adresgegevens |
| − | <section begin=mg-mp-mg-tst-MVE- | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
| + | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset7-v30-7-4 /><section end=mg-mp-mg-tst-MVE-Scenarioset7-v30-7-4 /> | ||
| + | == TEST Medicatiegegevens MVE Scenarioset 8== | ||
| + | <section begin=mg-mp-mg-tst-MVE-Scenarioset8-v30-8-1 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-1 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.040: | Regel 2.126: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|L. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 2.051: | Regel 2.137: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|van | + | |style="background-color: white;"|van |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Meijs |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900808 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|26 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mg-mp-mg-tst-MVE- | + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-1 /> |
| − | ==== Scenario | + | ==== Scenario 8.1 - MBH_300_VVandermansMA-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_MVEandermansTA_MVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.075: | Regel 2.161: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_MVEandermansTA_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 10:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.085: | Regel 2.171: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|6 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM AUROBINDO RET TABLET MGA 100MG (code = '630608' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VVandermansMA_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_VVandermansMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_MVEandermansTA_andermansMVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_MVEandermansTA_andermansMVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
| + | |style="background-color: white;"|T - 14 dagen om 10:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"|Zorgaanbieder | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="3"|VerstrekteHoeveelheid |
| − | |style="background-color: white;"|Apotheek De Gulle Gaper | + | |style="background-color: white;"|21 stuks |
| − | |}<section end=mbhs-mg-mp-mg-tst-MVE- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | == TEST Medicatiegegevens MVE Scenarioset | + | |colspan="3"|Geneesmiddel - primaire code |
| − | <section begin=mg-mp-mg-tst-MVE- | + | |style="background-color: white;"|DICLOFENAC NATRIUM AUROBINDO RET TABLET MGA 100MG (code = '630608' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieVerstrekkingsverzoek | ||
| + | |style="background-color: white;"|MBH_300_VVandermansMA_andermansVV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_VVandermansMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset8-v30-8-1 /> | ||
| + | == TEST Medicatiegegevens MVE Scenarioset 8== | ||
| + | <section begin=mg-mp-mg-tst-MVE-Scenarioset8-v30-8-2 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-2 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.139: | Regel 2.263: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|L. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
| Regel 2.150: | Regel 2.274: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|van | + | |style="background-color: white;"|van |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Meijs |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900808 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|26 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mg-mp-mg-tst-MVE- | + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-2 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-2 /> |
| − | ==== Scenario | + | ==== Scenario 8.2 - MBH_300_stakenandermansMA-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_stakenandermansTA_andermansMVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.174: | Regel 2.298: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stakenandermansTA_andermansMVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 5 dagen om 09:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.187: | Regel 2.308: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|21 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stakenandermansMA_andermansVV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stakenandermansMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.218: | Regel 2.336: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| − | |}<section end=mbhs-mg-mp-mg-tst-MVE- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | == TEST Medicatiegegevens MVE Scenarioset | + | |colspan="2"|Adresgegevens |
| − | <section begin=mg-mp-mg-tst-MVE- | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
| + | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-2 /><section end=mg-mp-mg-tst-MVE-Scenarioset8-v30-8-2 /> | ||
| + | == TEST Medicatiegegevens MVE Scenarioset 8== | ||
| + | <section begin=mg-mp-mg-tst-MVE-Scenarioset8-v30-8-3 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-3 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.239: | Regel 2.360: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|L. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| − | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan="2"| | + | |rowspan="3"| |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Meijs |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900808 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|26 okt 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mg-mp-mg-tst-MVE- | + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-3 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-3 /> |
| − | ==== Scenario | + | ==== Scenario 8.3 - MBH_300_onderbrekenandermansMA-tmg==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_onderbrekenandermansTA_andermansMVE-tmg |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.273: | Regel 2.397: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbrekenandermansTA_andermansMVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|MedicatieverstrekkingsDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 60 dagen om 10:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.283: | Regel 2.407: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|VerstrekteHoeveelheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|90 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RelatieVerstrekkingsverzoek |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbrekenandermansMA_andermansVV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbrekenandermansMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.314: | Regel 2.435: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-3 /><section end=mg-mp-mg-tst-MVE-Scenarioset8-v30-8-3 /> | ||
| + | == TEST Medicatiegegevens MVE Scenarioset 8== | ||
| + | <section begin=mg-mp-mg-tst-MVE-Scenarioset8-v30-8-4 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-4 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Voornamen | ||
| + | |style="background-color: white;"|L. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Meijs | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900808 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|26 okt 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-4 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-4 /> | ||
| + | ==== Scenario 8.4 - MBH_300_wijzigenandermansMA-tmg==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_wijzigenandermansTA_andermansMVE-tmg | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigenandermansTA_andermansMVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
| + | |style="background-color: white;"|T - 7 dagen om 08:50 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekteHoeveelheid | ||
| + | |style="background-color: white;"|42 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieVerstrekkingsverzoek | ||
| + | |style="background-color: white;"|MBH_300_wijzigenandermansMA_andermansVV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigenandermansMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset8-v30-8-4 /><section end=mg-mp-mg-tst-MVE-Scenarioset8-v30-8-4 /> | ||
| + | == TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | ||
| + | <section begin=mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1a /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1a /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|M. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van de | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Tewarie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900961 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|9 nov 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1a /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1a /> | ||
| + | ==== Scenario 9.1a - MBH_300_logistiekeverbruiksperiode_start_eind-tmg==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmg | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
| + | |style="background-color: white;"|T om 12:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekteHoeveelheid | ||
| + | |style="background-color: white;"|100 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Verbruiksduur | ||
| + | |style="background-color: white;"|100 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieVerstrekkingsverzoek | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_start_eind-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1a /><section end=mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1a /> | ||
| + | == TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | ||
| + | <section begin=mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1b /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1b /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|M. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van de | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Tewarie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900961 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|9 nov 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1b /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1b /> | ||
| + | ==== Scenario 9.1b - MBH_300_distributievorm_GDS-tmg==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_distributievorm_GDS_MVE-tmg | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_distributievorm_GDS_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
| + | |style="background-color: white;"|T - 9 dagen om 12:01 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekteHoeveelheid | ||
| + | |style="background-color: white;"|14 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Verbruiksduur | ||
| + | |style="background-color: white;"|14 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Distributievorm | ||
| + | |style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieVerstrekkingsverzoek | ||
| + | |style="background-color: white;"|MBH_300_distributievorm_GDS_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_distributievorm_GDS-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1b /><section end=mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1b /> | ||
| + | == TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | ||
| + | <section begin=mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1c /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1c /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|M. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van de | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Tewarie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900961 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|9 nov 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1c /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1c /> | ||
| + | ==== Scenario 9.1c - MBH_300_logistiekeverbruiksperiode_duur_dagen-tmg==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmg | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
| + | |style="background-color: white;"|T om 12:02 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekteHoeveelheid | ||
| + | |style="background-color: white;"|50 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Verbruiksduur | ||
| + | |style="background-color: white;"|50 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieVerstrekkingsverzoek | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_logistiekeverbruiksperiode_duur_dagen-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1c /><section end=mg-mp-mg-tst-MVE-Scenarioset9-v30-9-1c /> | ||
| + | == TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | ||
| + | <section begin=mg-mp-mg-tst-MVE-Scenarioset9-v30-9-2 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-2 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|M. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van de | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Tewarie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900961 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|9 nov 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-2 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-2 /> | ||
| + | ==== Scenario 9.2 - MBH_300_herhalingen-tmg==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE1-tmg | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_herhalingen_MVE1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
| + | |style="background-color: white;"|T - 50 dagen om 12:05 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekteHoeveelheid | ||
| + | |style="background-color: white;"|30 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieVerstrekkingsverzoek | ||
| + | |style="background-color: white;"|MBH_300_herhalingen_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_herhalingen-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE2-tmg | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_herhalingen_MVE2-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
| + | |style="background-color: white;"|T - 20 dagen om 10:24:05 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekteHoeveelheid | ||
| + | |style="background-color: white;"|30 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieVerstrekkingsverzoek | ||
| + | |style="background-color: white;"|MBH_300_herhalingen_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_herhalingen-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_herhalingen_MVE3-tmg | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_herhalingen_MVE3-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
| + | |style="background-color: white;"|T + 10 dagen om 09:46:48 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekteHoeveelheid | ||
| + | |style="background-color: white;"|30 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieVerstrekkingsverzoek | ||
| + | |style="background-color: white;"|MBH_300_herhalingen_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_herhalingen-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-2 /><section end=mg-mp-mg-tst-MVE-Scenarioset9-v30-9-2 /> | ||
| + | == TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)== | ||
| + | <section begin=mg-mp-mg-tst-MVE-Scenarioset9-v30-9-3 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-3 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|M. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van de | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Tewarie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900961 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|9 nov 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-3 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-3 /> | ||
| + | ==== Scenario 9.3 - MBH_300_afleverlocatie-tmg==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_afleverlocatie_MVE-tmg | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_afleverlocatie_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
| + | |style="background-color: white;"|T om 12:07 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|AanschrijfDatum | ||
| + | |style="background-color: white;"|T om 11:07 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekteHoeveelheid | ||
| + | |style="background-color: white;"|30 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|MODAFINIL FOCUS TABLET 200MG (code = '2842246' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Afleverlocatie | ||
| + | |style="background-color: white;"|Dorpsrand 200,1256ZZ Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieVerstrekkingsverzoek | ||
| + | |style="background-color: white;"|MBH_300_afleverlocatie_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_afleverlocatie-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset9-v30-9-3 /><section end=mg-mp-mg-tst-MVE-Scenarioset9-v30-9-3 /> | ||
| + | == TEST Medicatiegegevens MVE Scenarioset 10 (ZI)== | ||
| + | <section begin=mg-mp-mg-tst-MVE-Scenarioset10-v30-10-1 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset10-v30-10-1 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|J. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Bree | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999901588 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|1 jul 2010 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset10-v30-10-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset10-v30-10-1 /> | ||
| + | ==== Scenario 10.1 - MBH_300_ZINRvoorschrijven-tmg==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE-tmg | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MedicatieverstrekkingsDatumTijd | ||
| + | |style="background-color: white;"|T om 14:05 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|VerstrekteHoeveelheid | ||
| + | |style="background-color: white;"|150 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RelatieVerstrekkingsverzoek | ||
| + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset10-v30-10-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset10-v30-10-1 /> | |}<section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset10-v30-10-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset10-v30-10-1 /> | ||
| + | == TEST Medicatiegegevens MVE Scenarioset 14 (geen medicatie)== | ||
| + | <section begin=mg-mp-mg-tst-MVE-Scenarioset14-v30-14-1 /><section begin=patient-mg-mp-mg-tst-MVE-Scenarioset14-v30-14-1 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|S. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Tewariem | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999901126 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|24 nov 1985 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mg-mp-mg-tst-MVE-Scenarioset14-v30-14-1 /><section begin=mbhs-mg-mp-mg-tst-MVE-Scenarioset14-v30-14-1 /><section end=mbhs-mg-mp-mg-tst-MVE-Scenarioset14-v30-14-1 /><section end=mg-mp-mg-tst-MVE-Scenarioset14-v30-14-1 /> | ||
[[Categorie:Kwalificatie]] | [[Categorie:Kwalificatie]] | ||
Huidige versie van 26 feb 2026 om 10:59
Inhoud
- 1 Addenda voor inhoudelijke gegevens
- 1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
- 1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
- 1.3 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
- 1.4 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
- 1.5 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
- 1.6 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
- 1.7 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
- 1.8 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
- 1.9 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
- 1.10 TEST Medicatiegegevens MVE Scenarioset 1
- 1.11 TEST Medicatiegegevens MVE Scenarioset 2
- 1.12 TEST Medicatiegegevens MVE Scenarioset 2
- 1.13 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)
- 1.14 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)
- 1.15 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)
- 1.16 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)
- 1.17 TEST Medicatiegegevens MVE Scenarioset 8
- 1.18 TEST Medicatiegegevens MVE Scenarioset 8
- 1.19 TEST Medicatiegegevens MVE Scenarioset 8
- 1.20 TEST Medicatiegegevens MVE Scenarioset 8
- 1.21 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)
- 1.22 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)
- 1.23 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)
- 1.24 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)
- 1.25 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)
- 1.26 TEST Medicatiegegevens MVE Scenarioset 10 (ZI)
- 1.27 TEST Medicatiegegevens MVE Scenarioset 14 (geen medicatie)
1 Addenda voor inhoudelijke gegevens
1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
1.1.1 Scenarioset 0
Onderstaand scenario 0.1 bevat in het antwoord alle bouwstenen voor de patiënt. De daaropvolgende scenario's passen steeds een filter toe, waardoor het antwoord een subset van de bouwstenen uit scenario 0.1 bevat. Bij inhoudelijke gegevens staat om die reden alleen scenario 0.1 opgenomen. Deze omvat immers alle bouwstenen van alle subscenario's.
In de tabel staat bij elk scenario benoemd hoeveel van alle bouwstenen deze bevat (maar niet welke).
| Scenario | Screenshots? | Beschrijving |
| 0.1 | Alle verstrekkingen van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 6 verstrekkingen) | |
| 0.2 | Specifieke verstrekking met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_QA1_MVE" invoeren) (Antwoord: bericht met 1 verstrekking)
| |
| 0.3 optioneel | Verstrekkingen met een filter op productcode (PRK 3956) (Antwoord: bericht met 1 verstrekking)
| |
| 0.4 | Verstrekking met een filter op verstrekkingsperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 3 verstrekkingen)
| |
| 0.5 | Verstrekkingen met een filter op verstrekkingsperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 verstrekkingen)
| |
| 0.6 | Verstrekkingen met een filter op verstrekkingsperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 2 verstrekkingen)
| |
| 0.7 | Verstrekkingen met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_QA1" invoeren) (Antwoord: bericht met 1 verstrekking)
|
1.1.2 Scenarioset 1
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 1.1 | Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie) |
MBH_300_chronisch-tmg | MBH_300_chronisch_MVE-tmg MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmg |
1.1.3 Scenarioset 2
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 2.1 | Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden | Toelichting | MBH_300_toelichting-tmg | MBH_300_toelichting_MVE-tmg |
| 2.2 | Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is | Aanvullende informatie | MBH_300_aanvullendeinformatiewensen-tmg | MBH_300_aanvullendeinformatiewensen_MVE-tmg |
1.1.4 Scenarioset 7
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 7.1 | Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden | Alle ingrediënten | MBH_300_magistraalalleingredienten-tmg | MBH_300_magistraalalleingredienten_MVE-tmg |
| 7.2 | Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden | Actief ingrediënt | MBH_300_magistraalactieveingredient-tmg | MBH_300_magistraalactieveingredient_MVE-tmg |
| 7.3 | Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt | 90 miljoen nummer | MBH_300_magistraal90miljoennr-tmg | MBH_300_magistraal90miljoennr_MVE-tmg |
| 7.4 | Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt | Vrije tekst product | MBH_300_vrijetekstproduct-tmg | MBH_300_vrijetekstproduct_MVE-tmg |
1.1.5 Scenarioset 8
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 8.1 | VV onder andermans MA | MBH_300_VVandermansMA-tmg | MBH_300_MVEandermansTA_MVE-tmg MBH_300_MVEandermansTA_andermansMVE-tmg | |
| 8.2 | Staken andermans MA | MBH_300_stakenandermansMA-tmg | MBH_300_stakenandermansTA_andermansMVE-tmg | |
| 8.3 | Onderbreken andermans MA (met kopie indicator) | MBH_300_onderbrekenandermansMA-tmg | MBH_300_onderbrekenandermansTA_andermansMVE-tmg | |
| 8.4 | Wijzigen andermans MA | MBH_300_wijzigenandermansMA-tmg | MBH_300_wijzigenandermansTA_andermansMVE-tmg |
1.1.6 Scenarioset 9
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 9.1a | Logistieke verbruiksperiode | MBH_300_logistiekeverbruiksperiode_start_eind-tmg | MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmg | |
| 9.1b | GDS | MBH_300_distributievorm_GDS-tmg | MBH_300_distributievorm_GDS_MVE-tmg | |
| 9.1c | Verbruiksduur | MBH_300_logistiekeverbruiksperiode_duur_dagen-tmg | MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmg | |
| 9.2 | Herhalende MVE onder een VV | MBH_300_herhalingen-tmg | MBH_300_herhalingen_MVE1-tmg MBH_300_herhalingen_MVE2-tmg MBH_300_herhalingen_MVE3-tmg | |
| 9.3 | Maak screenshot(s) waarop zichtbaar is dat de afleverlocatie ingevuld kan worden | Afleverlocatie en aanschrijfdatum | MBH_300_afleverlocatie-tmg | MBH_300_afleverlocatie_MVE-tmg |
1.1.7 Scenarioset 10
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 10.1 | ZI-nr geneesmiddel | MBH_300_ZINRvoorschrijven-tmg | MBH_300_ZINRvoorschrijven_MVE-tmg |
1.1.8 Scenarioset 14
| Scenario | Screenshots? | Beschrijving | MBH id | MVE id |
| 14.1 | Een antwoord zonder medicatieverstrekkingen |
1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
1.2.1 Scenarioset 0
Onderstaand scenario 0.1 bevat in het antwoord alle bouwstenen voor de patiënt. De daaropvolgende scenario's passen steeds een filter toe, waardoor het antwoord een subset van de bouwstenen uit scenario 0.1 bevat. Bij inhoudelijke gegevens staat om die reden alleen scenario 0.1 opgenomen. Deze omvat immers alle bouwstenen van alle subscenario's.
In de tabel staat bij elk scenario benoemd hoeveel van alle bouwstenen deze bevat (maar niet welke).
| Scenario | Beschrijving |
| 0.1 | Alle verstrekkingen van de patiënt, zonder aanvullend filtercriterium (Antwoord: bericht met 6 verstrekkingen) |
| 0.2 | Specifieke verstrekking met identificaties als filter (in kwalificatiesimulator het id van "MBH_300_QA1_MVE" invoeren) (Antwoord: bericht met 1 verstrekking)
|
| 0.3 | Verstrekkingen met een filter op productcode (PRK 3956) (Antwoord: bericht met 1 verstrekking)
|
| 0.4 | Verstrekking met een filter op verstrekkingsperiode – ingangsdatum (alles vanaf T-21) (Antwoord: bericht met 3 verstrekkingen)
|
| 0.5 | Verstrekkingen met een filter op verstrekkingsperiode – einddatum (alles voor T-22) (Antwoord: bericht met 3 verstrekkingen)
|
| 0.6 | Verstrekkingen met een filter op verstrekkingsperiode – ingangsdatum én einddatum (alles vanaf T-21 tot en met T-7) (Antwoord: bericht met 2 verstrekkingen)
|
| 0.7 | Verstrekkingen met een specifieke medicamenteuze behandeling als filter (in kwalificatiesimulator het id van "MBH_300_QA1" invoeren) (Antwoord: bericht met 1 verstrekking)
|
1.2.2 Scenarioset 1
| Scenario | Beschrijving | MBH id | MVE id |
| 1.1 | Meerdere verstrekkingen onder dezelfde MBH (chronische medicatie) |
MBH_300_chronisch-tmg | MBH_300_chronisch_MVE-tmg MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmg |
1.2.3 Scenarioset 2
| Scenario | Beschrijving | MBH id | MVE id |
| 2.1 | Toelichting | MBH_300_toelichting-tmg | MBH_300_toelichting_MVE-tmg |
| 2.2 | Aanvullende informatie | MBH_300_aanvullendeinformatiewensen-tmg | MBH_300_aanvullendeinformatiewensen_MVE-tmg |
1.2.4 Scenarioset 7
| Scenario | Beschrijving | MBH id | MVE id |
| 7.1 | Alle ingrediënten | MBH_300_magistraalalleingredienten-tmg | MBH_300_magistraalalleingredienten_MVE-tmg |
| 7.2 | Actief ingrediënt | MBH_300_magistraalactieveingredient-tmg | MBH_300_magistraalactieveingredient_MVE-tmg |
| 7.3 | 90 miljoen nummer | MBH_300_magistraal90miljoennr-tmg | MBH_300_magistraal90miljoennr_MVE-tmg |
| 7.4 | Vrije tekst product | MBH_300_vrijetekstproduct-tmg | MBH_300_vrijetekstproduct_MVE-tmg |
1.2.5 Scenarioset 8
| Scenario | Beschrijving | MBH id | MVE id |
| 8.1 | VV onder andermans MA | MBH_300_VVandermansMA-tmg | MBH_300_MVEandermansTA_MVE-tmg MBH_300_MVEandermansTA_andermansMVE-tmg |
| 8.2 | Staken andermans MA | MBH_300_stakenandermansMA-tmg | MBH_300_stakenandermansTA_andermansMVE-tmg |
| 8.3 | Onderbreken andermans MA (met kopie indicator) | MBH_300_onderbrekenandermansMA-tmg | MBH_300_onderbrekenandermansTA_andermansMVE-tmg |
| 8.4 | Wijzigen andermans MA | MBH_300_wijzigenandermansMA-tmg | MBH_300_wijzigenandermansTA_andermansMVE-tmg |
1.2.6 Scenarioset 9
| Scenario | Beschrijving | MBH id | MVE id |
| 9.1a | Logistieke verbruiksperiode | MBH_300_logistiekeverbruiksperiode_start_eind-tmg | MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmg |
| 9.1b | GDS | MBH_300_distributievorm_GDS-tmg | MBH_300_distributievorm_GDS_MVE-tmg |
| 9.1c | Verbruiksduur | MBH_300_logistiekeverbruiksperiode_duur_dagen-tmg | MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmg |
| 9.2 | Herhalende MVE onder een VV | MBH_300_herhalingen-tmg | MBH_300_herhalingen_MVE1-tmg MBH_300_herhalingen_MVE2-tmg MBH_300_herhalingen_MVE3-tmg |
| 9.3 | Afleverlocatie en aanschrijfdatum | MBH_300_afleverlocatie-tmg | MBH_300_afleverlocatie_MVE-tmg |
1.2.7 Scenarioset 10
| Scenario | Beschrijving | MBH id | MVE id |
| 10.1 | ZI-nr geneesmiddel | MBH_300_ZINRvoorschrijven-tmg | MBH_300_ZINRvoorschrijven_MVE-tmg |
1.2.8 Scenarioset 14
| Scenario | Beschrijving | MBH id | MVE id |
| 14.1 | Een antwoord zonder medicatieverstrekkingen |
1.3 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.3.1 Scenario 0.1 - MBH_300_QA1-tmg
| Medicatieverstrekking MBH_300_QA1_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA1_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 20 dagen om 09:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 60 stuks | ||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA1_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.2 Scenario 0.1 - MBH_300_QA2-tmg
| Medicatieverstrekking MBH_300_QA2_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA2_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 100 dagen om 09:04 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 300 ml | ||
| Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA2_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA2-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.3 Scenario 0.1 - MBH_300_QA3-tmg
| Medicatieverstrekking MBH_300_QA3_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA3_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 50 dagen om 09:10 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 4000 ml | ||
| Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA3_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA3-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.4 Scenario 0.1 - MBH_300_QA4-tmg
| Medicatieverstrekking MBH_300_QA4_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA4_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 10 dagen om 09:12 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA4_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA4-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.5 Scenario 0.1 - MBH_300_QA5-tmg
| Medicatieverstrekking MBH_300_QA5_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA5_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 50 dagen om 09:15 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 56 stuks | ||
| Geneesmiddel - primaire code | PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA5_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA5-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.6 Scenario 0.1 - MBH_300_QA6-tmg
| Medicatieverstrekking MBH_300_QA6_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA6_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 5 dagen om 09:18 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 21 stuks | ||
| Geneesmiddel - primaire code | OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA6_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA6-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.7 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.4 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.4.1 Scenario 0.2 - MBH_300_QA1-tmg
| Medicatieverstrekking MBH_300_QA1_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA1_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 20 dagen om 09:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 60 stuks | ||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA1_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.4.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.5 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.5.1 Scenario 0.3 - MBH_300_QA4-tmg
| Medicatieverstrekking MBH_300_QA4_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA4_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 10 dagen om 09:12 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA4_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA4-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.5.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.6 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.6.1 Scenario 0.4 - MBH_300_QA1-tmg
| Medicatieverstrekking MBH_300_QA1_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA1_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 20 dagen om 09:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 60 stuks | ||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA1_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.6.2 Scenario 0.4 - MBH_300_QA4-tmg
| Medicatieverstrekking MBH_300_QA4_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA4_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 10 dagen om 09:12 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA4_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA4-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.6.3 Scenario 0.4 - MBH_300_QA6-tmg
| Medicatieverstrekking MBH_300_QA6_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA6_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 5 dagen om 09:18 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 21 stuks | ||
| Geneesmiddel - primaire code | OXAZEPAM ACTAVIS TABLET 10MG (code = '613401' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA6_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA6-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.6.4 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.7 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.7.1 Scenario 0.5 - MBH_300_QA2-tmg
| Medicatieverstrekking MBH_300_QA2_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA2_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 100 dagen om 09:04 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 300 ml | ||
| Geneesmiddel - primaire code | XPRAEP SIROOP 2MG/ML (code = '101079' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | SENNOSIDEN A+B 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA2_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA2-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.7.2 Scenario 0.5 - MBH_300_QA3-tmg
| Medicatieverstrekking MBH_300_QA3_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA3_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 50 dagen om 09:10 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 4000 ml | ||
| Geneesmiddel - primaire code | NUTRIDRINK BANAANSMAAK (code = '690090' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA3_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA3-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.7.3 Scenario 0.5 - MBH_300_QA5-tmg
| Medicatieverstrekking MBH_300_QA5_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA5_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 50 dagen om 09:15 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 56 stuks | ||
| Geneesmiddel - primaire code | PARACETAMOL SANDOZ TABLET 500MG (code = '665800' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA5_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA5-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.7.4 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.8 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.8.1 Scenario 0.6 - MBH_300_QA1-tmg
| Medicatieverstrekking MBH_300_QA1_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA1_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 20 dagen om 09:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 60 stuks | ||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA1_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.8.2 Scenario 0.6 - MBH_300_QA4-tmg
| Medicatieverstrekking MBH_300_QA4_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA4_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 10 dagen om 09:12 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA4_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA4-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.8.3 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.9 TEST Medicatiegegevens MVE Scenarioset 0 (filterqueries)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | R. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Sonnenberg | |||
| Adresgegevens | krommeweg 1001 A 1234QQ Ons Dorp 157 Nederland 3 Woon-/verblijfadres | |||
| Identificatienummer | 999901084 [BSN] | |||
| Geboortedatum | 20 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.9.1 Scenario 0.7 - MBH_300_QA1-tmg
| Medicatieverstrekking MBH_300_QA1_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_QA1_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 20 dagen om 09:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 60 stuks | ||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_QA1_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_QA1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.9.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.10 TEST Medicatiegegevens MVE Scenarioset 1
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | D. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Dijks | |||
| Identificatienummer | 999900468 [BSN] | |||
| Geboortedatum | 21 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.10.1 Scenario 1.1 - MBH_300_chronisch-tmg
| Medicatieverstrekking MBH_300_chronisch_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 30 dagen om 12:32 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 21 stuks | ||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_chronisch_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_chronisch-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieverstrekking MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_MVE_extraMVEbestaandeTA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 10 dagen om 12:35 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 90 stuks | ||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_chronisch_VV_extraVVbestaandeMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_chronisch-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.10.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.11 TEST Medicatiegegevens MVE Scenarioset 2
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | D. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Dixhoorn | |||
| Identificatienummer | 999900481 [BSN] | |||
| Geboortedatum | 22 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.11.1 Scenario 2.1 - MBH_300_toelichting-tmg
| Medicatieverstrekking MBH_300_toelichting_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toelichting_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 21 dagen om 09:02 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Toelichting | Extra verstrekkingsverzoek omdat patient medicatie is kwijtgeraakt | ||
| RelatieVerstrekkingsverzoek | MBH_300_toelichting_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_toelichting-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.11.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.12 TEST Medicatiegegevens MVE Scenarioset 2
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | D. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Dixhoorn | |||
| Identificatienummer | 999900481 [BSN] | |||
| Geboortedatum | 22 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.12.1 Scenario 2.2 - MBH_300_aanvullendeinformatiewensen-tmg
| Medicatieverstrekking MBH_300_aanvullendeinformatiewensen_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_aanvullendeinformatiewensen_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 5 dagen om 09:06 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 40 stuks | ||
| Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| MedicatieverstrekkingAanvullendeInformatie | Aantal bewust gewijzigd (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2052') | ||
| RelatieVerstrekkingsverzoek | MBH_300_aanvullendeinformatiewensen_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_aanvullendeinformatiewensen-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.12.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.13 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Rambaran Mishre | |||
| Identificatienummer | 999900948 [BSN] | |||
| Geboortedatum | 8 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.13.1 Scenario 7.1 - MBH_300_magistraalalleingredienten-tmg
| Medicatieverstrekking MBH_300_magistraalalleingredienten_MVE-tmg | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalalleingredienten_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| MedicatieverstrekkingsDatumTijd | T om 13:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| VerstrekteHoeveelheid | 50 ml | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| Ingredient | ||||
| IngredientCode | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 90 gram per 100 gram | |||
| RelatieVerstrekkingsverzoek | MBH_300_magistraalalleingredienten_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| MBH identificatie | MBH_300_magistraalalleingredienten-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.13.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.14 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Rambaran Mishre | |||
| Identificatienummer | 999900948 [BSN] | |||
| Geboortedatum | 8 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.14.1 Scenario 7.2 - MBH_300_magistraalactieveingredient-tmg
| Medicatieverstrekking MBH_300_magistraalactieveingredient_MVE-tmg | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalactieveingredient_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| MedicatieverstrekkingsDatumTijd | T om 13:05 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| VerstrekteHoeveelheid | 75 gram | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Vaseline 20% in cetomacrogolcrème FNA | |||
| Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | |||
| Ingredient | ||||
| IngredientCode | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 80 gram per 100 gram | |||
| RelatieVerstrekkingsverzoek | MBH_300_magistraalactieveingredient_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| MBH identificatie | MBH_300_magistraalactieveingredient-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.14.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.15 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Rambaran Mishre | |||
| Identificatienummer | 999900948 [BSN] | |||
| Geboortedatum | 8 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.15.1 Scenario 7.3 - MBH_300_magistraal90miljoennr-tmg
| Medicatieverstrekking MBH_300_magistraal90miljoennr_MVE-tmg | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraal90miljoennr_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | |||
| MedicatieverstrekkingsDatumTijd | T om 13:08 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| VerstrekteHoeveelheid | 100 gram | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductCode | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| RelatieVerstrekkingsverzoek | MBH_300_magistraal90miljoennr_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | |||
| MBH identificatie | MBH_300_magistraal90miljoennr-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.15.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.16 TEST Medicatiegegevens MVE Scenarioset 7 (Magistraal)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Rambaran Mishre | |||
| Identificatienummer | 999900948 [BSN] | |||
| Geboortedatum | 8 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.16.1 Scenario 7.4 - MBH_300_vrijetekstproduct-tmg
| Medicatieverstrekking MBH_300_vrijetekstproduct_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_vrijetekstproduct_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 1 dag om 15:50 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 4 stuks | ||
| Geneesmiddel - ProductSpecificatie | |||
| ProductNaam | Jemperli 500 mg/ 10 mL | ||
| Omschrijving | Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
| RelatieVerstrekkingsverzoek | MBH_300_vrijetekstproduct_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_vrijetekstproduct-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.16.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.17 TEST Medicatiegegevens MVE Scenarioset 8
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | L. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Meijs | |||
| Identificatienummer | 999900808 [BSN] | |||
| Geboortedatum | 26 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.17.1 Scenario 8.1 - MBH_300_VVandermansMA-tmg
| Medicatieverstrekking MBH_300_MVEandermansTA_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_MVEandermansTA_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 10:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 6 stuks | ||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM AUROBINDO RET TABLET MGA 100MG (code = '630608' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_VVandermansMA_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_VVandermansMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieverstrekking MBH_300_MVEandermansTA_andermansMVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_MVEandermansTA_andermansMVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 14 dagen om 10:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 21 stuks | ||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM AUROBINDO RET TABLET MGA 100MG (code = '630608' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_VVandermansMA_andermansVV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_VVandermansMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.17.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.18 TEST Medicatiegegevens MVE Scenarioset 8
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | L. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Meijs | |||
| Identificatienummer | 999900808 [BSN] | |||
| Geboortedatum | 26 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.18.1 Scenario 8.2 - MBH_300_stakenandermansMA-tmg
| Medicatieverstrekking MBH_300_stakenandermansTA_andermansMVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stakenandermansTA_andermansMVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 5 dagen om 09:45 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 21 stuks | ||
| Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | ||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_stakenandermansMA_andermansVV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_stakenandermansMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.19 TEST Medicatiegegevens MVE Scenarioset 8
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | L. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Meijs | |||
| Identificatienummer | 999900808 [BSN] | |||
| Geboortedatum | 26 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.19.1 Scenario 8.3 - MBH_300_onderbrekenandermansMA-tmg
| Medicatieverstrekking MBH_300_onderbrekenandermansTA_andermansMVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_onderbrekenandermansTA_andermansMVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 60 dagen om 10:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 90 stuks | ||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_onderbrekenandermansMA_andermansVV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_onderbrekenandermansMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.19.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.20 TEST Medicatiegegevens MVE Scenarioset 8
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | L. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Meijs | |||
| Identificatienummer | 999900808 [BSN] | |||
| Geboortedatum | 26 okt 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.20.1 Scenario 8.4 - MBH_300_wijzigenandermansMA-tmg
| Medicatieverstrekking MBH_300_wijzigenandermansTA_andermansMVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigenandermansTA_andermansMVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 7 dagen om 08:50 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 42 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_wijzigenandermansMA_andermansVV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_wijzigenandermansMA-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.20.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.21 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Tewarie | |||
| Identificatienummer | 999900961 [BSN] | |||
| Geboortedatum | 9 nov 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.21.1 Scenario 9.1a - MBH_300_logistiekeverbruiksperiode_start_eind-tmg
| Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_logistiekeverbruiksperiode_start_eind_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 12:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 100 stuks | ||
| Verbruiksduur | 100 dagen | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_logistiekeverbruiksperiode_start_eind_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_logistiekeverbruiksperiode_start_eind-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.21.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.22 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Tewarie | |||
| Identificatienummer | 999900961 [BSN] | |||
| Geboortedatum | 9 nov 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.22.1 Scenario 9.1b - MBH_300_distributievorm_GDS-tmg
| Medicatieverstrekking MBH_300_distributievorm_GDS_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_distributievorm_GDS_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 9 dagen om 12:01 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 14 stuks | ||
| Verbruiksduur | 14 dagen | ||
| Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| Distributievorm | GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||
| RelatieVerstrekkingsverzoek | MBH_300_distributievorm_GDS_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_distributievorm_GDS-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.22.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.23 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Tewarie | |||
| Identificatienummer | 999900961 [BSN] | |||
| Geboortedatum | 9 nov 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.23.1 Scenario 9.1c - MBH_300_logistiekeverbruiksperiode_duur_dagen-tmg
| Medicatieverstrekking MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_logistiekeverbruiksperiode_duur_dagen_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 12:02 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 50 stuks | ||
| Verbruiksduur | 50 dagen | ||
| Geneesmiddel - primaire code | PARACETAMOL PCH TABLET 500MG (code = '768901' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_logistiekeverbruiksperiode_duur_dagen_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_logistiekeverbruiksperiode_duur_dagen-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.23.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.24 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Tewarie | |||
| Identificatienummer | 999900961 [BSN] | |||
| Geboortedatum | 9 nov 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.24.1 Scenario 9.2 - MBH_300_herhalingen-tmg
| Medicatieverstrekking MBH_300_herhalingen_MVE1-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_herhalingen_MVE1-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 50 dagen om 12:05 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_herhalingen_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_herhalingen-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieverstrekking MBH_300_herhalingen_MVE2-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_herhalingen_MVE2-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T - 20 dagen om 10:24:05 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_herhalingen_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_herhalingen-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Medicatieverstrekking MBH_300_herhalingen_MVE3-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_herhalingen_MVE3-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T + 10 dagen om 09:46:48 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | FUROSEMIDE APOTEX TABLET 40MG (code = '1127047' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_herhalingen_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_herhalingen-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.24.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.25 TEST Medicatiegegevens MVE Scenarioset 9 (diversen MVE)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Tewarie | |||
| Identificatienummer | 999900961 [BSN] | |||
| Geboortedatum | 9 nov 1985 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.25.1 Scenario 9.3 - MBH_300_afleverlocatie-tmg
| Medicatieverstrekking MBH_300_afleverlocatie_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_afleverlocatie_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 12:07 uur | ||
| AanschrijfDatum | T om 11:07 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 30 stuks | ||
| Geneesmiddel - primaire code | MODAFINIL FOCUS TABLET 200MG (code = '2842246' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MODAFINIL TABLET 200MG (code = '199311' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MODAFINIL TABLET 200MG (code = '179051' in codeSystem 'G-Standaard GPK') | ||
| Afleverlocatie | Dorpsrand 200,1256ZZ Ons Dorp | ||
| RelatieVerstrekkingsverzoek | MBH_300_afleverlocatie_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_afleverlocatie-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.25.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.26 TEST Medicatiegegevens MVE Scenarioset 10 (ZI)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | J. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Bree | |||
| Identificatienummer | 999901588 [BSN] | |||
| Geboortedatum | 1 jul 2010 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.26.1 Scenario 10.1 - MBH_300_ZINRvoorschrijven-tmg
| Medicatieverstrekking MBH_300_ZINRvoorschrijven_MVE-tmg | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_ZINRvoorschrijven_MVE-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.373784005.1) | ||
| MedicatieverstrekkingsDatumTijd | T om 14:05 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| VerstrekteHoeveelheid | 150 stuks | ||
| Geneesmiddel - primaire code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
| RelatieVerstrekkingsverzoek | MBH_300_ZINRvoorschrijven_VV-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.52711000146108.1) | ||
| MBH identificatie | MBH_300_ZINRvoorschrijven-tmg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.26.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.27 TEST Medicatiegegevens MVE Scenarioset 14 (geen medicatie)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | S. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Tewariem | |||
| Identificatienummer | 999901126 [BSN] | |||
| Geboortedatum | 24 nov 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||